Hologic übernimmt den Marktführer für Biopsiemarker und Lokalisierungstechnologien SOMATEX für 64 Millionen US-Dollar pressnetwork.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressnetwork.de Daily Mail and Mail on Sunday newspapers.
Hologic To Acquire SOMATEX, Leader In Biopsy Site Markers And Localization Technologies, For $64M
Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced today it has completed the acquisition of SOMATEX Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately $64M. The company was previously owned by E-Med Solutions GmbH, Berlin, a group of investors led by German private equity company Westlake Partners.
The transaction supports Hologic’s strategy to provide a comprehensive suite of innovative solutions across the continuum of breast health care. Specifically, SOMATEX’s differentiated products will enable Hologic to strengthen and further expand its breast marker portfolio, which has been growing consistently. As a result of the acquisition, Hologi
Hologic Adds 3-D Breast Ultrasound Imaging to SuperSonic MACH 40 System
New software-based application helps clinicians visualize breast anatomy and provides detailed characterization of lesions
December 17, 2020 Hologic, Inc. announced that 3-D ultrasound imaging is now available on the SuperSonic MACH 40 ultrasound system. Clinicians can now access high-resolution B-mode and ShearWave PLUS elastography 3-D volumes, which are designed to enhance diagnostic certainty.
With the 3-D volumetric data acquired on the SuperSonic MACH 40 system, clinicians can see areas of interest from a new perspective. Breast tissue can be visualized in any scanning plane of the 3-D volume, including coronal or C-plane. MultiSlice display allows these 3D volumes to be viewed slice-by-slice, while MultiPlanar display virtually reconstructs the slices in any orientation using the acquired and stored volume. The system’s volumetric transducer allows users to easily and rapidly acquire these 3-D
SuperSonic Imagine: Hologic Adds 3D Breast Ultrasound Imaging to SuperSonic MACH 40 System
Regulatory News:
SuperSonic Imagine (Paris:SSI):
Hologic, Inc. (Nasdaq: HOLX) announced today 3D ultrasound imaging is now available on the SuperSonic MACH 40 ultrasound system . Clinicians can now access high-resolution B-mode and ShearWave PLUS elastography 3D volumes, which are designed to enhance diagnostic certainty.
With the 3D volumetric data acquired on the SuperSonic MACH 40 system, clinicians can see areas of interest from a new perspective. Breast tissue can be visualized in any scanning plane of the 3D volume, including coronal or C-plane. MultiSlice display allows these 3D volumes to be viewed slice-by-slice, while MultiPlanar display virtually reconstructs the slices in any orientation using the acquired and stored volume. The system s volumetric transducer allows users to easily and rapidly acquire these 3D images with no resolution loss, regardless of where a lesion is lo
Marlborough, MA-based Hologic won FDA clearance for the Genius AI Detection technology, a new deep learning-based software.
Hologic took a giant step in detecting subtle potential cancers in breast tomosynthesis images. The Marlborough, MA-based company received clearance for the company’s Genius AI Detection technology, a new deep learning-based software.
The company said the new software delivers key metrics at the time of image acquisition to help radiologists categorize and prioritize cases by complexity and expected read time in order to optimize workflow and expedite patient care.
“Consider this one-day workflow: After the acquisition of patient images, Genius AI Detection provides results to the technologist in less than a minute,” Jennifer Meade, Division President, Breast & Skeletal Health Solutions, Hologic, told MD+DI. “Based on the case score, the algorithm flags a percentage of cases as having a higher level of concern. If a patient’s exam is flagged,